These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33283139)

  • 21. Breakthrough Cancer Pain: Ten Commandments.
    Mercadante S; Cuomo A
    Value Health; 2016; 19(5):531-6. PubMed ID: 27565269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breakthrough cancer pain (BTcP) management: a review of international and national guidelines.
    Davies AN; Elsner F; Filbet MJ; Porta-Sales J; Ripamonti C; Santini D; Webber K
    BMJ Support Palliat Care; 2018 Sep; 8(3):241-249. PubMed ID: 29875184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Once again... breakthrough cancer pain: an updated overview.
    Mercadante S
    J Anesth Analg Crit Care; 2023 Jul; 3(1):23. PubMed ID: 37480136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breakthrough Cancer Pain in Patients With Abdominal Visceral Cancer Pain.
    Mercadante S; Adile C; Masedu F; Valenti M; Aielli F
    J Pain Symptom Manage; 2019 May; 57(5):966-970. PubMed ID: 30822530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of sublingual fentanyl vs. oral morphine for cancer-related breakthrough pain.
    Velázquez Rivera I; Muñoz Garrido JC; García Velasco P; España Ximénez de Enciso I; Velázquez Clavarana L
    Adv Ther; 2014 Jan; 31(1):107-17. PubMed ID: 24385406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A European survey of oncology nurse breakthrough cancer pain practices.
    Rustøen T; Geerling JI; Pappa T; Rundström C; Weisse I; Williams SC; Zavratnik B; Kongsgaard UE; Wengström Y
    Eur J Oncol Nurs; 2013 Feb; 17(1):95-100. PubMed ID: 22742829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakthrough cancer pain: The importance of the right treatment at the right time.
    O'Hagan P; Mercadante S
    Eur J Pain; 2018 Aug; 22(7):1362-1374. PubMed ID: 29635732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion.
    ; Vellucci R; Fanelli G; Pannuti R; Peruselli C; Adamo S; Alongi G; Amato F; Consoletti L; Lamarca L; Liguori S; Lo Presti C; Maione A; Mameli S; Marinangeli F; Marulli S; Minotti V; Miotti D; Montanari L; Moruzzi G; Palermo S; Parolini M; Poli P; Tirelli W; Valle A; Romualdi P
    Drugs; 2016 Mar; 76(3):315-30. PubMed ID: 26755179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON).
    Porta-Sales J; Pérez C; Escobar Y; Martínez V
    Clin Transl Oncol; 2016 Sep; 18(9):945-54. PubMed ID: 26693731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canadian recommendations for the management of breakthrough cancer pain.
    Daeninck P; Gagnon B; Gallagher R; Henderson JD; Shir Y; Zimmermann C; Lapointe B
    Curr Oncol; 2016 Apr; 23(2):96-108. PubMed ID: 27122974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies.
    Mercadante S; Valle A; Porzio G; Aielli F; Adile C; Ficorella C; Raineri M; Giarratano A; Casuccio A
    Curr Med Res Opin; 2013 Jun; 29(6):667-71. PubMed ID: 23551065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer.
    Magnani C; Giannarelli D; Calvieri A; Dardeli A; Eusepi G; Restuccia MR; Mastroianni C; Casale G
    Postgrad Med J; 2018 Oct; 94(1116):566-570. PubMed ID: 30317182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study.
    Boceta J; De la Torre A; Samper D; Farto M; Sánchez-de la Rosa R
    Clin Transl Oncol; 2016 Nov; 18(11):1088-1097. PubMed ID: 26856600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compliance with the breakthrough cancer pain European guidelines and impact on patients' quality of life: an observational prospective study.
    Bossi P; Pietrzyńska T; Margarit Ferri C; Mansilla I; Tellone V; Fioravanti S; Di Loreto G; Comandini A
    Front Pain Res (Lausanne); 2024; 5():1388837. PubMed ID: 39006759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practice Patterns in Distinguishing Between Background Pain and Breakthrough Pain During Patient Education: a Korean Physician Survey.
    Shin J; Kim DY; Lee J; Choi YS; Hwang IG; Baek SK; Seo MS; Shim JY
    J Cancer Educ; 2018 Apr; 33(2):284-292. PubMed ID: 27623849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Korean Nationwide Survey for Breakthrough Cancer Pain in an Inpatient Setting.
    Baek SK; Kim DY; Kang SY; Sym SJ; Kim YS; Lee JY
    Cancer Res Treat; 2016 Apr; 48(2):768-74. PubMed ID: 26511815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment and treatment of breakthrough cancer pain: from theory to clinical practice.
    Vellucci R; Mediati RD; Gasperoni S; Mammucari M; Marinangeli F; Romualdi P
    J Pain Res; 2017; 10():2147-2155. PubMed ID: 29066928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of rapid onset opioids for breakthrough cancer pain: the challenge of its dosing.
    Mercadante S
    Crit Rev Oncol Hematol; 2011 Dec; 80(3):460-5. PubMed ID: 21215653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients.
    Mercadante S; Adile C; Torta R; Varetto A; Fulfaro F; Giarratano A; Casuccio A
    Curr Med Res Opin; 2013 Jan; 29(1):93-7. PubMed ID: 23198976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm.
    Canal-Sotelo J; Trujillano-Cabello J; Larkin P; Arraràs-Torrelles N; González-Rubió R; Rocaspana-Garcia M; Barallat-Gimeno E
    BMC Palliat Care; 2018 May; 17(1):81. PubMed ID: 29807537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.